keyword
https://read.qxmd.com/read/37801317/autoimmune-and-autoinflammatory-connective-tissue-disorders-following-covid-19
#21
JOURNAL ARTICLE
Sung Ha Lim, Hyun Jeong Ju, Ju Hee Han, Ji Hae Lee, Won-Soo Lee, Jung Min Bae, Solam Lee
IMPORTANCE: Multiple cases of autoimmune and autoinflammatory diseases after COVID-19 have been reported. However, their incidences and risks have rarely been quantified. OBJECTIVE: To investigate the incidences and risks of autoimmune and autoinflammatory connective tissue disorders after COVID-19. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective population-based study conducted between October 8, 2020, and December 31, 2021, that used nationwide data from the Korea Disease Control and Prevention Agency COVID-19 National Health Insurance Service cohort and included individuals who received a diagnosis of COVID-19 via polymerase chain reaction testing and a control group with no evidence of COVID-19 identified from National Health Insurance Service of Korea cohort...
October 2, 2023: JAMA Network Open
https://read.qxmd.com/read/37646004/cerebral-aneurysms-and-recurrent-tias-in-a-42-year-old-patient-with-dada2-mutation-a-case-report
#22
JOURNAL ARTICLE
Netta Agajany, Liran Horev, Netanel Agajany, Gilad Kenan
OBJECTIVES: Deficiency of adenosine deaminase 2 (DADA2) is a rare, recessively inherited autoinflammatory disease with a wide clinical spectrum of manifestations, including strokes and vasculitis. METHODS: We report a case of a patient with DADA2 who presented with neurologic manifestations. RESULTS: A 42-year-old woman with a known diagnosis of polyarteritis nodosa experienced several episodes of TIAs. Neuroimaging revealed 2 aneurysms in unusual locations...
October 2023: Neurology. Genetics
https://read.qxmd.com/read/37624921/recurrent-flare-associated-urticaria-in-adenosine-deaminase-type-2-deficiency
#23
JOURNAL ARTICLE
Priyanka Priyanka, Pratap Kumar Patra, Aaqib Zaffar Banday, Pakkiresh Reddy, Nutan Sharma, Jannarthanan Jannarthanan, Dharmagat Bhattarai
No abstract text is available yet for this article.
August 25, 2023: Rheumatology
https://read.qxmd.com/read/37622085/interferonopathies-masquerading-as-non-mendelian-autoimmune-diseases-pattern-recognition-for-early-diagnosis
#24
REVIEW
Samuel Gagne, Vidya Sivaraman, Shoghik Akoghlanian
Type I interferonopathies are a broad category of conditions associated with increased type I interferon gene expression and include monogenic autoinflammatory diseases and non-Mendelian autoimmune diseases such as dermatomyositis and systemic lupus erythematosus. While a wide range of clinical presentations among type I interferonopathies exists, these conditions often share several clinical manifestations and implications for treatment. Presenting symptoms may mimic non-Mendelian autoimmune diseases, including vasculitis and systemic lupus erythematosus, leading to delayed or missed diagnosis...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/37620906/pediatric-onset-limited-anca-associated-vasculitis-arising-during-pre-existing-chronic-recurrent-multifocal-osteomyelitis
#25
JOURNAL ARTICLE
Esraa Eloseily, Michael Henrickson
BACKGROUND: Granulomatosis with polyangiitis (GPA) is an autoimmune disease characterized by chronic vasculitis involving small to medium sized arteries, granulomatous inflammation of the upper and lower respiratory tracts, pauci-immune necrotizing glomerulonephritis, as well as vasculitis of other organs. Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory syndrome characterized by sterile bone inflammation. CASE PRESENTATION: We report a case of CRMO that was doing well on non-steroidal anti-inflammatory drugs (NSAID for 6 years and then developed ANCA positive limited GPA presenting with pyoderma gangrenosum, persistent bilateral otalgia with serous otitis, otorrhea, then sensorineural hearing loss...
August 24, 2023: Pediatric Rheumatology Online Journal
https://read.qxmd.com/read/37595794/episcleritis-and-periorbital-edema-secondary-to-vexas-syndrome
#26
P Fanlo, M López de San Román, A Fonollosa, J Ilarramendi, H Heras, P Grayson
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly described autoinflammatory entity caused by a UBA-1 gene mutation. Among the most frequent symptoms it produces fever, cytopenias, polychondritis, pulmonary infiltrates and up to 40% ocular involvement such as periorbital edema, uveitis, episcleritis, scleritis and retinal vasculitis. Patients respond to high doses of corticosteroids, however, many end up being refractory to them and to the classic immunosuppressants. We described the case of a 77-year-old male patient with ocular involvement in the form of episcleritis and periorbital edema who was later diagnosed with VEXAS Syndrome...
October 2023: Archivos de la Sociedad Española de Oftalmología
https://read.qxmd.com/read/37548813/a-narrative-review-of-the-neurological-manifestations-of-human-adenosine-deaminase-2-deficiency
#27
JOURNAL ARTICLE
Mariia Dzhus, Lisa Ehlers, Marjon Wouters, Katrien Jansen, Rik Schrijvers, Lien De Somer, Steven Vanderschueren, Marco Baggio, Leen Moens, Benjamin Verhaaren, Rik Lories, Giorgia Bucciol, Isabelle Meyts
Deficiency of human adenosine deaminase type 2 (DADA2) is a complex systemic autoinflammatory disorder characterized by vasculopathy, immune dysregulation, and hematologic abnormalities. The most notable neurological manifestations of DADA2 are strokes that can manifest with various neurological symptoms and are potentially fatal. However, neurological presentations can be diverse. We here present a review of the neurological manifestations of DADA2 to increase clinical awareness of DADA2 as the underlying diagnosis...
August 7, 2023: Journal of Clinical Immunology
https://read.qxmd.com/read/37536165/clinical-features-and-long-term-outcomes-of-patients-with-systemic-polyarteritis-nodosa-diagnosed-since-2005-data-from-196-patients
#28
JOURNAL ARTICLE
Julien Rohmer, Yann Nguyen, Ludovic Trefond, Christian Agard, Jean Sebastien Allain, Alice Berezne, Pierre Charles, Pascal Cohen, Guillaume Gondran, Matthieu Groh, Tessa Huscenot, Carole Lacout, Estibaliz Lazaro, Jonathan London, François Maurier, Arsène Mekinian, Rafik Mesbah, Isabelle Nubourgh, Laurent Perard, Xavier Puéchal, Gregory Pugnet, Mathieu Puyade, Viviane Queyrel, Arthur Roux, Diane Rouzaud, Cecile-Audrey Durel, Loïc Guillevin, Benjamin Terrier
BACKGROUND: The landscape of polyarteritis nodosa (PAN) has substantially changed during the last decades. Recent data regarding causes, characteristics, and prognosis of systemic PAN in the modern era are lacking. METHODS: This retrospective study included patients with systemic PAN referred to the French Vasculitis Study Group between 2005 and 2019. Characteristics, associated conditions and outcomes were collected, and predictors of relapse and death were analyzed...
September 2023: Journal of Autoimmunity
https://read.qxmd.com/read/37532466/vexas-syndrome-a-diagnostic-puzzle
#29
JOURNAL ARTICLE
Nikolas Ruffer, Martin Krusche
The VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is an adult-onset systemic autoinflammatory condition that is caused by an acquired deficiency of the UBA1 gene in hematopoietic progenitor cells. The clinical spectrum of the VEXAS syndrome currently comprises a broad range of phenotypes such as vasculitis, relapsing polychondritis and Sweet's syndrome. In the past, VEXAS patients have left clinicians puzzled and the true nature of this disease has not been captured until late 2020...
August 2023: RMD Open
https://read.qxmd.com/read/37497206/kidney-involvement-in-autoinflammatory-diseases
#30
REVIEW
Changming Zhang, Jiahui Peng, Zhihong Liu, Qing Zhou
BACKGROUND: Autoinflammatory diseases (AIDs) were first proposed 20 years ago and caused by dysregulation of the innate immune system, leading to episodes of systemic inflammation. Advances in next-generation sequencing and biological technology have resulted in the identification of new monogenic diseases and the corresponding signaling pathways that may guide us in targeted therapy. The kidney is a major target organ of various inflammatory processes. SUMMARY: During systemic inflammation, increased pro-inflammatory cytokines, such as IL-6, IL-1β, and TNF, lead to over-transcription and release of acute phase reactant serum amyloid A (SAA)...
May 2023: Kidney Diseases
https://read.qxmd.com/read/37481715/pyrin-variant-e148q-potentiates-inflammasome-activation-and-the-effect-of-pathogenic-mutations-in-cis
#31
JOURNAL ARTICLE
Thomas Reygaerts, Pawat Laohamonthonkul, Katja Hrovat-Schaale, Fiona Moghaddas, Paul J Baker, Paul E Gray, Seth L Masters
OBJECTIVE: The p.E148Q variant in pyrin is present in different populations at a frequency up to 29%, and has been associated with diseases including vasculitis and familial Mediterranean fever (FMF). The pathogenicity of p.E148Q in FMF is unclear, even when observed in cis or in trans to a single, typically recessive, mutation. We performed functional validation to determine whether p.E148Q increases the ability of pyrin to form an active inflammasome complex in cell lines. METHODS: We interrogated the Australian Autoinflammatory Disease RegistrY (AADRY) to find candidate inheritance patterns for the p...
July 22, 2023: Rheumatology
https://read.qxmd.com/read/37480098/vacuoles-e1-enzyme-x-linked-autoinflammatory-and-somatic-syndrome-in-the-intensive-care-unit-a%C3%A2-case-report
#32
JOURNAL ARTICLE
Félicie Belicard, Nicolas Belhomme, Simon Bouzy, Clémence Saillard, Fabienne Nedelec, Jean-Baptiste Mear, Samuel Ardois, Cedric Pastoret, Florian Reizine, Christophe Camus, Benoit Painvin
BACKGROUND: Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome is a newly discovered inflammatory disease affecting male subjects, for which few data exist in the literature. Here, we describe the case of a patient with known Sweet's syndrome admitted to the intensive care unit and for whom a vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome was diagnosed, allowing for appropriate treatment and the patient's discharge and recovery. CASE PRESENTATION: A 70-year-old male White patient was hospitalized in the intensive care unit following an intrahospital cardiac arrest...
July 22, 2023: Journal of Medical Case Reports
https://read.qxmd.com/read/37443545/kawasaki-disease-and-inborn-errors-of-immunity-exploring-the-link-and-implications
#33
REVIEW
Saniya Sharma, Pallavi L Nadig, Rakesh Kumar Pilania, Kaushal Sharma, Manpreet Dhaliwal, Amit Rawat, Surjit Singh
The exact etiopathogenesis of Kawasaki disease (KD), the most common childhood vasculitis, remains unknown; however, an aberrant immune response, possibly triggered by an infectious or environmental agent in genetically predisposed children, is believed to be the underlying pathogenetic mechanism. Patients with inborn errors of immunity (IEI) are predisposed to infections that trigger immune dysregulation due to an imbalance in various arms of the immune system. KD may develop as a complication in both primary and secondary immunodeficiencies...
June 23, 2023: Diagnostics
https://read.qxmd.com/read/37430338/a-case-of-vexas-syndrome-presenting-with-unusual-bone-marrow-granulomas-a-diagnostic-dilemma
#34
JOURNAL ARTICLE
Khiem T Vu, Rachel M Wolfe, Jonathan E Lambird, Danielle L V Maracaja
BACKGROUND: VEXAS is a recently described inflammatory disease caused by mutations in the UBA1 gene. Symptoms are diverse and include fevers, cartilaginous inflammation, lung inflammation, vasculitis, neutrophilic dermatoses, and macrocytic anemia. Cytoplasmic inclusions in myeloid and erythroid progenitors in the bone marrow are a hallmark feature. Here we report the first case of VEXAS with non-caseating granulomas in the bone marrow. CASE PRESENTATION: A 62-year-old Asian male presented with fevers, erythema nodosum, inflammatory arthritis, and periorbital inflammation...
July 10, 2023: BMC rheumatology
https://read.qxmd.com/read/37418279/vexas-syndrome-with-tracheal-involvement-but-absence-of-vasculitis-in-fdg-pet-ct
#35
JOURNAL ARTICLE
Niklas Lohaus, Jan Schaab, Dominik Schaer, Stefan Balabanov, Martin W Huellner
In early 2022, a 77-year-old man presented with weight loss and recurrent subfebrile temperatures since 6 months. Workup with CT revealed a lung infiltrate. Despite antibiotic treatment, serum inflammation markers remained high. The patient further developed eczematous skin changes, uveitis (sequentially on both eyes), and macrocytic anemia. Finally, an autoinflammatory disease was suspected, and FDG PET/CT was performed. The examination revealed metabolically active foci in several tissues (tracheal cartilage, bone marrow, muscles)...
September 1, 2023: Clinical Nuclear Medicine
https://read.qxmd.com/read/37405738/an-orbital-manifestation-of-vexas-syndrome
#36
JOURNAL ARTICLE
Anagha Lokhande, Spandana Jarmale, Yash J Vaishnav, Jamie Schaefer
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is an adult-onset autoinflammatory disorder characterized by systemic inflammation (vasculitis, arthritis, chondritis, dermatosis) and hematologic abnormalities (thrombosis, cytopenia, vacuolization of marrow precursors). The patient demonstrated some of the adult-onset inflammatory and hematologic features, in addition to recurrent eye pain, chemosis and orbital inflammation. This case describes an instance of VEXAS syndrome in a patient with uncommon orbital symptoms such as scleritis and myositis...
November 2023: Ophthalmic Plastic and Reconstructive Surgery
https://read.qxmd.com/read/37395471/tofacitinib-in-pyoderma-gangrenosum-a-case-series
#37
Vanitha Agrahara Sathyanarayana, Debaditya Roy, Bhavya Nagaraju, Vijay K R Rao
Pyoderma gangrenosum (PG) is a rare autoinflammatory disorder falling under the spectrum of neutrophilic dermatosis, characterized by distinctive skin ulceration which is non-infective, non-neoplastic and usually with no primary vasculitis. PG lesions are notorious for relapse and hence require multiple trials of medications often with prolonged and concomitant use of steroids. Due to lack of evidence-based studies on effective treatment options for PG, we have presented three isolated biopsy-proven PG cases who were successfully treated with Tofacitinib, a Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway inhibitor, without relapse in follow up...
July 3, 2023: International Journal of Rheumatic Diseases
https://read.qxmd.com/read/37328410/deficiency-of-adenosine-deaminase-2-dada2-review
#38
REVIEW
Vikas Sharma, Prateek Deo, Aman Sharma
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease caused by loss-of-function (LOF) mutations in the ADA2 gene and was first described in 2014. Initially, it was described as vasculopathy/vasculitis that mostly affected infants and young children and closely resembled polyarteritis nodosa (PAN). Skin rash and ischemic/hemorrhagic stroke are predominant symptoms. However, the clinical spectrum of DADA2 has continued to expand since then. It has now been reported in adults as well...
March 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37312195/a-case-series-of-ten-plus-one-deficiency-of-adenosine-deaminase-2-dada2-patients-in-iran
#39
JOURNAL ARTICLE
Kosar Asna Ashari, Nahid Aslani, Nima Parvaneh, Raheleh Assari, Morteza Heidari, Mohammadreza Fathi, Fatemeh Tahghighi Sharabian, Alireza Ronagh, Mohammad Shahrooei, Alireza Moafi, Nima Rezaei, Vahid Ziaee
BACKGROUND: Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease caused by mutations in the ADA2 gene. DADA2 has a broad spectrum of clinical presentations. Apart from systemic manifestations, we can categorize most of the signs and symptoms of DADA2 into the three groups of vasculitis, hematologic abnormalities, and immunologic dysregulations. The most dominant vasculitis features are skin manifestations, mostly in the form of livedo racemosa/reticularis, and early onset ischemic or hemorrhagic strokes...
June 13, 2023: Pediatric Rheumatology Online Journal
https://read.qxmd.com/read/37309797/-restatement-relapsing-polychondritis
#40
JOURNAL ARTICLE
Philippe Mertz, Laurent Arnaud
RELAPSING POLYCHONDRITIS. Relapsing polychondritis (RP) is a systemic disease which diagnosis relies on the existence of typical chondritis present at the beginning of the disease only in 1/3 of cases. Three phenotypes of RP have been described, each one characterized by specific manifestations and the need of a specific therapeutic management and follow-up. Screening for tracheo-bronchial manifestations must be systematic if RP is suspected, as it is responsible for most of the morbi-mortality of the disease...
May 2023: La Revue du Praticien
keyword
keyword
8289
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.